Literature DB >> 26309591

Impacts of K562 cells towards activities of Toll-like receptor pathway of human mesenchymal stem cell-bone marrow.

Zheng Xu1, Jianmin Luo1, Lin Yang1, Xingzhe Wang1, Yuxia Pan1, Yintao Shang1, Jingci Yang1.   

Abstract

The study aim was to investigate the impacts of K562 cells towards the activities of Toll-like receptor pathway of human mesenchymal stem cell-bone marrow (HMSC-bm). The in vitro co-culture of HMSC-bm and K562 cells was set as the experiment group (HMSC-bm + K562), the HMSC-bm cultured alone was set as the control group (HMSC-bm), the expressions of six interested genes and their proteins, namely MyD88, P38, NF-κB, TAB1, TLR3 and TBK1, of the Toll -like receptor signaling pathway were detected and compared, as well as the secretions of such cytokines as IL-6, IL-8, TNF-α and IFN-α in the cell supernatant, which were regulated by the Toll-like receptor pathway. The expressions of MyD88, P38, TAB1 and TLR3 of the HMSC-bm + K562 group were higher than the HMSC-bm group, while that of TBK1 was lower, and the NF-κB expression showed no significant difference between the two groups (P > 0.05). Compared with the HMSC-bm group, the supernatant of HMSC-bm + K562 group exhibited the higher secretion levels of IL-6 and IL-8, while that of IFN-α was just contrary, and the differences were significant (P < 0.05). The secretion levels of TNF-α within the two groups were not significantly different (P > 0.05). The co-culture of K562 and HMSC-bm could induce the activity changes of Toll-like receptor pathway of HMSC-bm, which was beneficial towards the proliferation of K562 cells.

Entities:  

Keywords:  Co-culture; HMSC-bm; K562; Toll-like receptor signaling pathway

Year:  2015        PMID: 26309591      PMCID: PMC4537973     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  26 in total

Review 1.  Survival of B lineage leukemic cells: signals from the bone marrow microenvironment.

Authors:  Laura F Gibson
Journal:  Leuk Lymphoma       Date:  2002-01

Review 2.  Mesenchymal stem cells: clinical applications and biological characterization.

Authors:  Frank P Barry; J Mary Murphy
Journal:  Int J Biochem Cell Biol       Date:  2004-04       Impact factor: 5.085

3.  Serum interleukin (IL)-1, IL-2, sIL-2Ra, IL-6 and thrombopoietin levels in patients with chronic myeloproliferative diseases.

Authors:  Katerina E Panteli; Eleftheria C Hatzimichael; Paraskevi K Bouranta; Afroditi Katsaraki; Konstantinos Seferiadis; Justin Stebbing; Konstantinos L Bourantas
Journal:  Br J Haematol       Date:  2005-09       Impact factor: 6.998

4.  [Influence of human mesenchymal stem cells on cell proliferation and chemo-sensitivity of K562 cells].

Authors:  Yu-Mei Lin; Li-Mei Bu; Shao-Juan Yang; Shen Gao; Gui-Zhen Zhang
Journal:  Zhongguo Shi Yan Xue Ye Xue Za Zhi       Date:  2006-04

5.  [Study of apoptosis gene expression in U937 cells induced by adhesion culture with mesenchymal stem cell].

Authors:  Yu-mei Lin; Gui-zhen Zhang; Zhen-xia Lu; Zong-xiang Leng; Li-sha Bu; Shen Gao
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2006-04

6.  Exosome-mediated crosstalk between chronic myelogenous leukemia cells and human bone marrow stromal cells triggers an interleukin 8-dependent survival of leukemia cells.

Authors:  Chiara Corrado; Stefania Raimondo; Laura Saieva; Anna Maria Flugy; Giacomo De Leo; Riccardo Alessandro
Journal:  Cancer Lett       Date:  2014-03-18       Impact factor: 8.679

7.  TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer.

Authors:  Michael G Kelly; Ayesha B Alvero; Rui Chen; Dan-Arin Silasi; Vikki M Abrahams; Serena Chan; Irene Visintin; Thomas Rutherford; Gil Mor
Journal:  Cancer Res       Date:  2006-04-01       Impact factor: 12.701

Review 8.  Harnessing the immune system to treat cancer.

Authors:  Nina Bhardwaj
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

9.  Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling.

Authors:  Bo Huang; Jie Zhao; Shiqian Shen; Hongxing Li; Kai-Li He; Guan-Xin Shen; Lloyd Mayer; Jay Unkeless; Dong Li; Ye Yuan; Gui-Mei Zhang; Huabao Xiong; Zuo-Hua Feng
Journal:  Cancer Res       Date:  2007-05-01       Impact factor: 12.701

10.  TLR3/TICAM-1 signaling in tumor cell RIP3-dependent necroptosis.

Authors:  Tsukasa Seya; Hiroaki Shime; Hiromi Takaki; Masahiro Azuma; Hiroyuki Oshiumi; Misako Matsumoto
Journal:  Oncoimmunology       Date:  2012-09-01       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.